Achieving the Optimal AgO Concentrations to Modulate the Anti-<i>Trypanosoma cruzi</i> Activity of Ag-ZnO/AgO Nanocomposites: In Vivo Investigations.

Pharmaceutics · 2024 · PMC11597568 · PMID 39598539

Europe PMC DOI

hedged sentence

0.0591

closest p · 1.2× alpha

0.0591

boldest claim

The sentences

showed a trendp = 0.0591so close (0.05 < p ≤ 0.1)

The group treated with ZnO:9Ag showed a trend towards reduced collagen deposition compared to that in the group treated with the ZnO nanocrystals ( p = 0.0591). 3.4.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.